Pebblebrook Hotel Trust (NYSE: PEB) is a Real Estate company in the REIT - Hotel & Motel industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
18.04
+0.05+0.28%
TA
Loading chart...
Snapshot
| Index | - | P/E | - | EPS (ttm) | -0.68 | Insider Own | 2.59% | Shs Outstand | 112.84M | Perf Week | 1.12% |
| Market Cap | 2.04B | Forward P/E | - | EPS next Y | -0.21 | Insider Trans | 2.05% | Shs Float | 103.77M | Perf Month | -1.90% |
| Enterprise Value | 4.24B | PEG | - | EPS next Q | 0.01 | Inst Own | - | Short Float | 16.43% | Perf Quarter | -5.35% |
| Income | -46.00M | P/S | 1.36 | EPS this Y | 57.35% | Inst Trans | - | Short Ratio | 6.83 | Perf Half Y | 46.79% |
| Sales | 1.50B | P/B | 0.81 | EPS next Y | 28.97% | ROA | -0.88% | Short Interest | 17.04M | Perf YTD | 59.36% |
| Book/sh | 22.27 | P/C | 7.80 | EPS next 5Y | - | ROE | -1.90% | 52W High | 19.93 -9.48% | Perf Year | 52.88% |
| Cash/sh | 2.31 | P/FCF | 8.82 | EPS past 3/5Y | - | ROIC | 1.31% | 52W Low | 9.99 80.58% | Perf 3Y | 27.04% |
| Dividend Est. | 0.04 (0.22%) | EV/EBITDA | 14.92 | Sales past 3/5Y | 1.97% 27.21% | Gross Margin | 18.02% | Volatility | 2.74% 2.84% | Perf 5Y | -14.38% |
| Dividend TTM | 0.04 (0.22%) | EV/Sales | 2.82 | EPS Y/Y TTM | -74.36% | Oper. Margin | 4.61% | ATR (14) | 0.53 | Perf 10Y | -36.59% |
| Dividend Ex-Date | Sep 30, 2026 | Quick Ratio | 0.87 | Sales Y/Y TTM | 3.30% | Profit Margin | -3.11% | RSI (14) | 48.57 | Recom | 2.86 |
| Dividend Gr. 3/5Y | 0.00% 0.00% | Current Ratio | 0.87 | EPS Q/Q | 172.44% | SMA20 | -0.20% | Beta | 1.43 | Target Price | 17.58 |
| Payout | -110.26% | Debt/Eq | 0.96 | Sales Q/Q | -0.25% | SMA50 | -2.32% | Rel Volume | 1.88 | Prev Close | 17.99 |
| Employees | 52 | LT Debt/Eq | 0.96 | Earnings | Oct 29 | SMA200 | 21.31% | Avg Volume | 2.27M | Price | 18.04 |
| IPO Date | Dec 09, 2009 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 41.67% 1.77% | Net Debt/EBITDA | 7.75 | Volume | 4,260,259 | Change | 0.28% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-27-26 | Reiterated | Barclays | Underweight | $15 → $14 |
| Aug-11-26 | Reiterated | Cantor Fitzgerald | Neutral | $15 → $19 |
| Jul-31-26 | Upgrade | Compass Point | Sell → Neutral | $15 → $20 |
| Jul-23-26 | Reiterated | Wells Fargo | Equal Weight | $20 → $19 |
| Jul-21-26 | Reiterated | Barclays | Underweight | $13 → $15 |
| Jun-29-26 | Reiterated | Truist Securities | Buy | $17 → $22 |
| Jun-18-26 | Reiterated | Stifel Nicolaus | Buy | $18 → $20 |
| Jun-12-26 | Reiterated | BMO Capital | Market Perform | $15 → $17 |
| Jun-08-26 | Reiterated | Raymond James | Market Perform | $16 → $18 |
| Jun-01-26 | Reiterated | Barclays | Underweight | $10 → $13 |
Latest News· Times ET
Sep-15-26
03:00AM
Sep-11-26
Sep-11-2603:15AM
Sep-10-26
Sep-08-26
Sep-01-26
Sep-01-2611:50PM
Aug-31-26
Aug-31-2612:01AM
Aug-27-26
Aug-27-2607:23AM
Aug-26-26
Aug-26-2603:50AM
Aug-20-26
Aug-19-26
Aug-18-26
06:44AM
Aug-14-26
Aug-11-26
Aug-11-2603:49AM
Company
Pebblebrook Hotel Trust, identified by its NYSE ticker PEB, operates as a publicly listed real estate investment trust (REIT) and stands as the foremost proprietor of urban and resort lifestyle hotels throughout the United States. Its substantial portfolio encompasses 53 properties, collectively offering approximately 13,200 guestrooms, situated across 14 distinct urban and resort destinations, with a particular emphasis on key West Coast metropolitan areas.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,501 | 1,476 | 1,453 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,230 | 1,574 | 1,087 | — | — | — | — | — | — | |
| Gross Profit | 270 | -99 | 366 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 48 | 49 | 48 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 153 | -223 | 234 | — | — | — | — | — | — | |
| Operating Income | 69 | 75 | 84 | — | — | — | — | — | — | |
| Interest Expense | 75 | 103 | 102 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -27 | -28 | -7 | — | — | — | — | — | — | |
| Net Income Before Taxes | -32 | -56 | -26 | — | — | — | — | — | — | |
| Income Taxes | 10 | 6 | -26 | — | — | — | — | — | — | |
| Consolidated Net Income | -46 | -66 | -4 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | -42 | -62 | 0 | — | — | — | — | — | — | |
| Net Income | -46 | -66 | -4 | — | — | — | — | — | — | |
| EPS (Recurring) | -0.67 | -0.90 | -0.39 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.67 | -0.90 | -0.39 | — | — | — | — | — | — | |
| EPS (Diluted) | -0.68 | -0.90 | -0.39 | — | — | — | — | — | — | |
| EBITDA | 284 | 275 | 306 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.36 | 0.90 | 1.12 | — | — | — | — | — | — | |
| Gross Margin | 17.99 | -6.71 | 25.19 | — | — | — | — | — | — | |
| Operating Margin | 4.60 | 5.08 | 5.78 | — | — | — | — | — | — | |
| Net Margin | -3.06 | -4.47 | -0.28 | — | — | — | — | — | — | |
| Shares Outstanding | 113 | 117 | 120 | — | — | — | — | — | — | |
| Market Capitalization | 2,039 | 1,324 | 1,626 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Fisher Thomas Charles | Co-President, C Investmt Ofcr | Aug 03 '26 | Sale | 19.25 | 40,000 | 770,120 | 285,163 | Aug 04 |
| BORTZ JON E | Chairman and CEO | Jun 12 '26 | Buy | 18.18 | 20,000 | 363,600 | 1,657,110 | Jun 15 |
| BORTZ JON E | Chairman and CEO | Jun 11 '26 | Buy | 17.73 | 20,000 | 354,600 | 1,637,110 | Jun 12 |
| BORTZ JON E | Chairman and CEO | Jun 10 '26 | Buy | 17.23 | 20,000 | 344,600 | 1,617,110 | Jun 12 |
| BORTZ JON E | Chairman and CEO | Jun 09 '26 | Buy | 17.09 | 20,000 | 341,800 | 1,597,110 | Jun 09 |
| BORTZ JON E | Chairman and CEO | Jun 08 '26 | Buy | 16.84 | 20,000 | 336,800 | 1,577,110 | Jun 09 |
| BORTZ JON E | Chairman and CEO | Dec 15 '25 | Sale | 11.26 | 50,000 | 563,150 | 1,557,110 | Dec 16 |
| SCHALL MICHAEL J | Director | Nov 19 '25 | Buy | 10.85 | 10,000 | 108,500 | 119,693 | Nov 20 |
| SCHALL MICHAEL J | Director | Aug 19 '25 | Buy | 10.08 | 10,000 | 100,800 | 109,693 | Aug 21 |
| BORTZ JON E | Chairman and CEO | Jun 06 '25 | Buy | 9.50 | 5,000 | 47,500 | 1,607,110 | Jun 06 |
| BORTZ JON E | Chairman and CEO | May 30 '25 | Buy | 9.15 | 18,000 | 164,700 | 1,602,110 | May 30 |
| BORTZ JON E | Chairman and CEO | May 27 '25 | Buy | 9.00 | 6,000 | 54,000 | 1,584,110 | May 28 |
| Jackson Ron E. | Director | May 23 '25 | Buy | 8.91 | 10,000 | 89,100 | 106,898 | May 23 |
| BORTZ JON E | Chairman and CEO | May 22 '25 | Buy | 8.99 | 20,000 | 179,800 | 1,578,110 | May 23 |
| BORTZ JON E | Chairman and CEO | May 20 '25 | Buy | 9.73 | 23,213 | 225,862 | 1,558,110 | May 21 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.